Rodionov, E. O., Chernov, V., Kulbakin, D. E., Obkhodskaya, E. V., Obkhodsky, A. V., Sachkov, V. I., & Miller, S. V. (2023). Sensor-Based Gas Analysis System for Lung Cancer Diagnosis. Voprosy Onkologii, 69(5), 855–862. https://doi.org/10.37469/0507-3758-2023-69-5-855-862

Abstract

Aim. To examine exhaled air samples from lung cancer patients and identify shared signal markers detectable through an artificial neural network that ensures uniformity in the sampling process using a sensor-based gas analysis system.

Materials and methods. During the study, samples of exhaled air were collected from 90 individuals aged 22 to 95 years for the period of 2020-2021. All participants in the study were divided into two groups: the test and the control group. The main group included patients with morphologically verified lung malignancies at stage T1-4N0-3M0-1 (n = 21). The control group included individuals with no clinical data of malignant pathology at the time of the study (based on medical history or previous examination data, if available). A gas analysis system capable of analyzing gas samples in two modes - direct inhalation into the chamber or the use of gas sample bags was developed. This study used remote sampling from bags due to the COVID-19 pandemic.

Results. The accuracy of lung cancer diagnosis was 85.71 %, sensitivity was 95.24 %, and specificity was 76.19 %. The lung cancer diagnosis accuracy reached 85.71 %, with sensitivity at 95.24 % and specificity at 76.19 %. Key attributes of our method comprise equipment mobility, adaptability to various medical facilities, simplicity, cost-effectiveness, and unhindered tumor screening potential in a broad population.

https://doi.org/10.37469/0507-3758-2023-69-5-855-862

##article.numberofdownloads## 90

##article.numberofviews## 195

pdf (Русский)

References

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. https://doi.org/10.3322/caac.21551.

Arnold MJ, Zhang G. Lung cancer screening: guidelines from the american college of chest physicians. Am Fam Physician. 2023;107(1):100-102.

Родионов Е.О., Тузиков С.А., Миллер С.В., Кульбакин Д.Е., Чернов В.И. Методы ранней диагностики рака легкого (обзор литературы). Сибирский онкологический журнал. 2020;19(4):112-122. [Rodionov EO, Tuzikov SA, Miller SV, Kulbakin DE, Chernov VI. Methods for early detection of lung cancer (review). Siberian Journal of Oncology. 2020;19(4):112-122 (In Russ.)]. https://doi.org/10.21294/1814-4861-2020-19-4-112-122.

Mazzone PJ, Sears CR, Arenberg DA, et al. Evaluating molecular biomarkers for the early detection of lung cancer: when is a biomarker ready for clinical use? An official american thoracic society policy statement. Am J Respir Crit Care Med. 2017;196(7):e15-e29. https://doi.org/10.1164/rccm.201708-1678ST.

Sani SN, Zhou W, Ismail BB, et al. LC-MS/MS based volatile organic compound biomarkers analysis for early detection of lung cancer. Cancers. 2023;15(4):1186. https://doi.org/10.3390/cancers15041186.

Gordon SM, Szidon JP, Krotoszynski BK, et al. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem. 1985;31(8):1278-82.

Krilaviciute A, Heiss JA, Leja M, et al. Detection of cancer through exhaled breath: a systematic review. Oncotarget. 2015;6(36):38643-57. https://doi.org/10.18632/oncotarget.5938.

Sun X, Shao K, Wang T. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Anal Bioanal Chem. 2016;408(11):2759-80. https://doi.org/10.1007/s00216-015-9200-6.

van der Sar IG, Wijbenga N, Nakshbandi G, et al. The smell of lung disease: a review of the current status of electronic nose technology. Respir Res. 2021;22(1):246. https://doi.org/10.1186/s12931-021-01835-4.

Baldini C, Billeci L, Sansone F, et al. Electronic nose as a novel method for diagnosing cancer: a systematic review. Biosensors (Basel). 2020;10(8):84. https://doi.org/10.3390/bios10080084.

Chernov VI, Choynzonov EL, Kulbakin DE, et al. Cancer diagnosis by neural network analysis of data from semiconductor sensors. Diagnostics. 2020;10(9):677. https://doi.org/10.3390/diagnostics10090677.

Meng S, Li Q, Zhou Z, et al. Assessment of an exhaled breath test using high-pressure photon ionization time-of-flight mass spectrometry to detect lung cancer. JAMA Netw Open. 2021;4(3):e213486. https://doi.org/10.1001/jamanetworkopen.2021.3486.

Scheepers MHMC, Al-Difaie Z, Brandts L, et al. Diagnostic performance of electronic noses in cancer diagnoses using exhaled breath: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(6):e2219372. https://doi.org/10.1001/jamanetworkopen.2022.19372.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Natalya Chanchikova, Yekaterina Dudnikova, Yelena Karlova, Anastasiya Saveleva, O. Silkina, Roman Zelchan, Ivan Sinilkin, Olga Bragina, Anna Medvedeva, Vladimir Chernov, POSSIBILITIES OF 18F-FDG PET/CT IN THE DIAGNOSIS AND STAGING OF LYMPHOMAS , Voprosy onkologii: Vol. 65 No. 1 (2019)
Yuliya Belevich, Yelena Simolina, Vitalina Vysotskaya, Nataliya Popova, Denis Kulbakin, Aleksey Goldberg, Zhanna Startseva, Vladimir Chernov, Irina Frolova, Svetlana Chizhevskaya, Viktor Goldberg, Yevgeniy Choynzonov, Yekaterina Dudnikova, ANTITUMOR CHEMOTHERAPY IN COMBINED TREATMENT OF PATIENTS WITH CANCER OF THE LARYNX AND HYPOPHARYNX , Voprosy onkologii: Vol. 64 No. 5 (2018)
Alyena Chernyshova, Vitaly Аntipov, Larisa Коlomiets, Vladimir Chernov, Victor Gyunter, Ekaterina Маrchenko, Timofei Chekalkin, Experience of performing radical trachelectomy with uterine transposition in organ-preserving treatment of stage IB-II invasive cervical cancer , Voprosy onkologii: Vol. 67 No. 1 (2021)
Olga Bragina, Vladimir Chernov, Sergei Deev, Roman Zelchan, Anna Medvedeva, Natalia Lukina, Viktor Goldberg, Vladimir Tolmachev, Comparative analysis of the use of technetium-99m labeled recombinant target molecules at doses of 1000 and 2000 μg for radionuclide diagnostics of HER2-positive breast cancer , Voprosy onkologii: Vol. 68 No. 1 (2022)
Ol`ga Bragina, Vladimir Chernov, Liubov Tashireva, Roman Zelchan, Anna Medvedeva, Viktor Goldberg, Vladimir Tolmachev, Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6» , Voprosy onkologii: Vol. 67 No. 3 (2021)
Anna Medvedeva, Vladimir Chernov, Roman Zelchan, Olga Bragina, Anastasiya Rуbina, Artem Doroshenko, Evgenii Garbukov, Using the results of single-photon emission computed tomography with [99mTc]-MIBI at the stages of preoperative therapy in patients with breast cancer , Voprosy onkologii: Vol. 68 No. 4 (2022)